Expert Insights Into the Management of MPNs - Episode 11

Sequencing Therapies in Patients with MF

July 31, 2023

Jamile Shammo, MD, Naveen Pemmaraju, MD, Raajit K. Rampal, MD, PhD, Abdulraheem Yacoub, MD

Dr Jamile Shammo discusses how to approach sequencing therapies in patients with myelofibrosis and Dr Raajit Rampal explains the potential of the JAK inhibitor momelotinib in the treatment of myelofibrosis.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: An Overview of Myeloproliferative Neoplasms (MPNs)

EP. 2: Risk Assessment for Patients with Polycythemia Vera (PV)

EP. 3: Current Treatment Landscape for Patients With PV

EP. 4: Selecting a Frontline Therapy for Patients With PV

EP. 5: Ruxolitinib for the Management of PV

EP. 6: Ropeginterferon alfa-2b for the Treatment of PV

EP. 7: Reviewing the Types of Myelofibrosis

EP. 8: The Role of Transplant in the Treatment of Patients With MF

EP. 9: COMFORT-I and COMFORT-II Data Review

EP. 10: Pacritinib and Fedratinib for the Treatment of MF

Now Viewing

EP. 11: Sequencing Therapies in Patients with MF

EP. 12: Considering Toxicities and Side Effects of JAK Inhibitors in Patients with MF

EP. 13: Symptom Monitoring in Patients with MF

EP. 14: Exploring the Future of MF Treatment